We have assessed the optimal dose of succinylcholine to provide satisfactory conditions for insertion of a laryngeal mask airway (LMA) without causing myalgia during induction of anaesthesia with thiopental. We studied 60 adult patients, allocated randomly to one of three groups: group 1 (nϭ20) received normal saline, group 2 (nϭ20) received succinylcholine 0.25 mg kg -1 and group 3 (nϭ20) received succinylcholine 0.5 mg kg -1 . Insertion of the LMA was performed 1 min after administration of succinylcholine or saline. Insertion conditions were significantly better in group 3 compared with groups 1 and 2. The incidence of adverse responses on insertion was significantly higher in groups 1 and 2 than in group 3. Four of 20 patients (20%) in group 3 complained of myalgia, which was higher than that in group 1 (0%) and group 2 (10%), but there were no significant differences between groups on the day of operation. On day 3 after operation, seven patients (35%) in group 3 complained of myalgia, which was significantly higher than that in group 1 (5%) and group 2 (20%). Time from administration of succinylcholine to resumption of spontaneous respiration was significantly longer in groups 2 (194.9 (SD 50.4) s) and 3 (234.2 (34.3) s) than in group 1 (84.7 (32.4) s). There was also a significant difference between groups 3 and 2 for duration of apnoea. 1999; 83: 279-83 
Adverse responses to insertion of a laryngeal mask airway (LMA), such as gagging, coughing and laryngospasm, may make correct positioning difficult or even impossible. 1 Thiopental has been assessed for its usefulness in aiding LMA insertion but produces less satisfactory conditions than propofol. [2] [3] [4] Indeed, the Intavent LMA manual specifically recommends propofol for induction of anaesthesia. 5 However, there may be problems related to the use of propofol, including the relatively high cost of the drug. [6] [7] [8] [9] Stoneham, Bree and Sneyd reported that easy insertion of the LMA was seen in only approximately 62% of patients with propofol anaesthesia, 1 which means that the sole use of propofol does not always guarantee successful insertion of the LMA. They suggested that lidocaine 1.5 mg kg -1 i.v., given before induction of anaesthesia with propofol, provides satisfactory insertion conditions for the LMA. 1 Many other practitioners have also found the use of propofol alone to be unsatisfactory 10 11 and its routine use for LMA insertion has been questioned. 12 Much research has therefore been conducted using a variety of supplementary drugs to find a compound which eases LMA insertion. 4 10 11 Successful insertion of the LMA requires depression of © British Journal of Anaesthesia upper airway reflexes. 1 Drugs which suppress laryngeal reflexes, such as sedative premedication, midazolam, 10 fentanyl 11 and midazolam-alfentanil 4 i.v. may be useful in facilitating the early insertion technique. However, their use in short-term surgery may be contraindicated as the duration of action of these drugs is rather long. 11 13 Superior laryngeal nerve block with lidocaine has also been used in the early insertion technique. 14 Inhalation anaesthetics such as sevoflurane or isoflurane which suppress upper airway reflexes are used in the delayed insertion technique, but require 2 min or more to achieve adequate depth of anaesthesia for LMA insertion. 15 16 This time lag may be acceptable in certain cases. 15 Use of rapid onset, short-acting neuromuscular blocking drugs, such as succinylcholine, may be another method of choice, as these drugs suppress laryngeal reflexes by depolarization of motor neurone end-plates. 17 However, their use may result in significant myalgia. 18 Nimmo and †Presented in part at the 11th World Congress of Anaesthesiologists, Sydney, Australia, 1996 colleagues suggested that this can be avoided by reducing the doses substantially. 18 This study was designed to assess if low-dose succinylcholine aids insertion of the LMA without resulting in significant myalgia during thiopental anaesthesia.
Patients and methods
After obtaining approval from the Institution's Ethics Committee and informed consent, we studied 60 ASA I-II patients (aged 19-68 yr) undergoing elective body surface surgery under general anaesthesia using the LMA. Exclusion criteria were patients undergoing oral surgery, preoperative sore throat or operation duration exceeding 180 min. Patients were allocated randomly to one of three groups: group 1 (nϭ20) received normal saline; group 2 (nϭ20) received succinylcholine 0.25 mg kg -1 ; and group 3 (nϭ20) received succinylcholine 0.5 mg kg -1 .
The study drugs were diluted to equal volumes with physiological saline. They were then numbered by one of the authors (A. Y.). These were given randomly to the research worker who, with the anaesthetist, was blinded to the treatment administered at induction.
Patients were premedicated with hydroxidine 1 mg kg -1 i.m. which is an anti-histamine with very mild sedative effects, 1 h before operation. Anticholinergic drugs were avoided to prevent dehydration in the oral cavity, which may have influenced ease of insertion. Anaesthesia was induced with thiopental 5 mg kg -1 i.v. Study drugs were administered after confirmation that the patient had lost consciousness, as assessed by failure to respond to verbal commands and loss of the eyelash reflex. One minute after administration of the study drug, insertion of the LMA was attempted by one researcher with 10 yr experience in the use of the LMA. LMA insertion was performed as described in the Intavent instruction manual. 2 If more than one insertion attempt was required, the patient was kept adequately anaesthetized with inhalation of sevoflurane or additional thiopental before further attempts were made.
Jaw relaxation was graded according to the criteria of Young, Clarke and Dundee: 1ϭgood; 2ϭincomplete; and 3ϭpoor. 19 Overall insertion conditions were assessed according to the modified scheme of grading of intubation conditions by Lund and Stovner: 1ϭexcellent, insertion easy, no reaction from patient; 2ϭgood, insertion resulting in slight coughing or moving; 3ϭpoor, insertion possible but resulting in more marked patient response. 20 Incidences of gagging or coughing on insertion were scored on a four-point scale according to Nimmo and colleagues: 1ϭnone; 2ϭmild; 3ϭmoderate; and 4ϭ severe. 18 The incidence of laryngospasm and other complications was also noted. The presence of fasciculations was graded according to Mingus, Herlich and Eisenkraft: 1ϭno fasciculations; 2ϭmild fasciculations of the eyes, face, neck or fingers without limb movement; 3ϭmoderate fasciculations involving the limbs and/or trunk; and 4ϭ severe fasciculations with movement of one or more limbs. 21 Time to resumption of spontaneous respiration was also recorded. Anaesthesia was maintained with 1-3% sevoflurane and 66% nitrous oxide in oxygen. All patients received diclofenac 50 mg rectally for postoperative pain relief after induction. Postoperative rescue analgesics were not controlled. Patients were interviewed later on the day of operation and 3 days after surgery regarding muscle pain, which was scored according to Nimmo and colleagues: 1ϭnone; 2ϭ mild; 3ϭmoderate; and 4ϭsevere. 18 Statistical analysis was performed using analysis of variance (ANOVA) with Bonferroni's t test and chi-square test to compare patient groups, and Fisher's exact test to compare insertion conditions, degree of fasciculations and incidence of myalgia. Time from administration of succinylcholine to resumption of spontaneous respiration and duration of apnoea were compared using ANOVA with Bonferroni's t test. PϽ0.05 was considered statistically significant.
Results
There were no significant differences in patient characteristics between the three groups ( Table 1) .
There was no significant difference in the grade of jaw opening between groups (Table 2) . However, the incidences of gagging and coughing on insertion were significantly higher in groups 1 and 2 than in group 3 (Table 3) . Overall insertion conditions were significantly better in group 3 compared with groups 1 and 2 but there was no significant difference between groups 1 and 2 (Table 4) . Only one patient in group 1 had laryngospasm, which was treated successfully by administration of succinylcholine 1 mg kg -1 .
There was no significant difference in the incidence of postoperative myalgia between the three groups on the day of operation, although patients in group 3 complained of a slightly higher incidence of myalgia compared with groups 1 and 2. Three days after operation, the incidence of myalgia in group 3 was significantly higher than that in group 1, but there was no significant difference between groups 2 and 3 ( Table 5 ). The degree of fasciculations at induction of anaesthesia was significantly greater in groups 2 and 3 than in group 1, with no differences between groups 2 and 3 ( Table 6 ). Time from administration of succinylcholine to resumption of spontaneous respiration was significantly longer in groups 2 and 3 than in group 1. There was also a significant difference between groups 3 and 2 for duration of apnoea (Table 7) .
Discussion
Although rapid onset, short-acting, non-depolarizing neuromuscular blocking agents are available, they have yet to completely replace succinylcholine. 21 Succinylcholine is still useful for LMA insertion in patients undergoing body surface surgery where, in most cases, patients are then allowed to breathe spontaneously.
Although succinylcholine provides satisfactory neuromuscular block for tracheal intubation, it has several adverse effects, such as prolonged apnoea and true anaphylaxis, which limit its usefulness. One of the most frequent of these, although minor, is myalgia, occurring in up to 
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60% of patients receiving succinylcholine 1 mg kg -1 . 18 Pretreatment with a non-depolarizing neuromuscular blocking agent is effective in reducing both myalgia and the increase in creatine kinase, 22 albeit to the detriment of intubating conditions. 23 A reduction in postoperative myalgia using a reduced dose of succinylcholine (0.5 mg kg -1 ) for nasal intubation was demonstrated previously. Intubating conditions at this lower dose were equivalent to those seen with succinylcholine 1.5 mg kg -1 . 18 The incidence of myalgia was reduced from 70% to 41% when assessed over the first 4 days after surgery. 24 Although a reduction in succinylcholine dose to 0.5 mg kg -1 in our study was found to provide satisfactory insertion conditions for the LMA with a low incidence of gagging, coughing or other complications, this was not the case with the 0.25 mg kg -1 dose. It may not be possible to make direct comparisons between these results and the work of Nimmo and colleagues 18 because they intended to evaluate the effects of very low-dose succinylcholine for nasal intubation after induction of anaesthesia with a combination of propofol and alfentanil. The use of propofol combined with alfentanil has been shown to provide satisfactory conditions both for oral 26 and nasal 27 intubation in the majority of patients without neuromuscular block. The observations of Nimmo and colleagues 18 strongly support the supposition that the use of propofol combined with opioids for induction is superior to the combination of very low-dose succinylcholine and thiopental. Further studies of the propofol-alfentanil combination and thiopental as Although there was no significant difference in the grade of jaw opening between the groups with either dose of succinylcholine, the significantly lower incidences of gagging and coughing on insertion in the succinylcholine 0.5 mg kg -1 group resulted in significantly better overall insertion conditions than with succinylcholine 0.25 mg kg -1 . These findings suggest that residual upper airway reflexes, which may cause gagging and coughing, were a major cause of failed LMA insertion in this study. These were almost completely suppressed by succinylcholine 0.5 mg kg -1 but not by 0.25 mg kg -1 . Stoneham, Bree and Sneyd found that lidocaine i.v. provided good conditions for LMA insertion because of the reduced incidence of coughing as a result of suppression of laryngeal reflexes but did not improve the grade of jaw opening. 1 Taguchi and colleagues found that the amount of sevoflurane required to suppress upper airway reflexes for successful LMA insertion was lower than that for oral intubation. 28 Their results also support the findings of this study that standard and rather high doses of succinylcholine (1-2 mg kg -1 ) are not always necessary for LMA insertion but only for oral intubation.
There was no significant difference in the degree of fasciculations at induction of anaesthesia between groups 2 and 3. Furthermore, the incidence of myalgia in group 3 was equivalent to that in groups 1 and 2 on the day of operation. Although the incidence of myalgia in group 3 was significantly higher than that in group 1, 3 days after operation, the reason for this is unclear. It is possible that factors other than succinylcholine caused postoperative muscle pain 3 days after operation as one patient in group 1 who did not receive succinylcholine complained of mild myalgia. On the other hand, Nimmo and colleagues also recognized that patients who received succinylcholine 0.5 mg kg -1 had a higher incidence of muscle pain on days 1 and 5, but found no significant difference in the incidence of muscle pain between groups receiving either no succinylcholine or succinylcholine 0.25 mg kg -1 , probably because of the small number of patients. 18 In our study, the number of patients studied was small and this is also likely to be the cause of the lack of significant difference between groups 1 and 3 for the incidence of myalgia on the day of operation. Further study with a larger sample size would be necessary to elucidate this point. One concern with succinylcholine 0.5 mg kg -1 may be the longer duration of apnoea after its use at induction, although it is not difficult to perform controlled ventilation after LMA insertion until spontaneous respiration returns. 
